Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs
Go back to Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs| eLandia International, Inc. (NYSE: ELAN) | Delayed: 23.56 -0.34 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.90 | 52 Week High | $0.65 | |||
| Open | $23.71 | 52 Week Low | $0.03 | |||
| Day High | $23.95 | P/E | N/A | |||
| Day Low | $23.47 | EPS | $-0.60 | |||
| Volume | 965,593 | |||||
